SCHEMBL6984599

SCHEMBL6984599

CC1(C)CCC(C)(C)c2cc(C3(C(=O)O)OCC(c4ccccc4)(c4ccccc4)CO3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 17/20 0.53
RXRB P28702 7/20 0.49
CYP26A1 O43174 6/20 0.49
CYP26B1 Q9NR63 4/20 0.49
CYP3A4 P08684 2/20 0.45
RARB P10826 7/20 0.44
RARG P13631 7/20 0.44
RXRG P48443 5/20 0.44
RARA P10276 4/20 0.42
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981777 0.79 AKR1C1 (0.41) ALDH1A1LMNASMN1; SMN2
SCHEMBL6978477 0.76 LMNA (0.39) NPC1LMNATP53CYP1A2CYP2C19
SCHEMBL6971207 0.76 OPRM1 (0.44) NPC1USP2ALDH1A1TP53RAB9A
SCHEMBL6973280 0.76 SLC6A2 (0.37) CYP3A4KDM4ENPC1ALDH1A1POLB
SCHEMBL7760432 0.76 RXRA (0.69) RXRARXRBCYP26A1CYP26B1CYP3A4
SCHEMBL6971603 0.74 CHRNA1 (0.40) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL6967893 0.74 CNR1 (0.40) ALDH1A1
SCHEMBL6982594 0.74 HSD11B1 (0.39) CYP3A4NPC1POLBCYP2C19RAB9A
SCHEMBL6982070 0.71 AKR1C1 (0.40) ALDH1A1LMNACYP1A2NPSR1
SCHEMBL6981080 0.70 THRB (0.44) NPC1ALDH1A1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
EP-1098893-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GmbH (DE) 2001-05-16 EP disclosed
WO-2000004011-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDAEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2000-01-27 WO disclosed